Form 4 for MCRB Seres Therapeutics, Inc.
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-27 · accession 0000899243-22-034598 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-31 | 2022-10-31 | MCRB | Ege David S. | See Remarks | S - Sale | $7.93 | -5,012 | 46.7K | -10% | -$39.7K | |
| 2022-10-31 | 2022-10-27 | MCRB | Ege David S. | See Remarks | A - Grant | $0.00 | +20.0K | 51.7K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-10-31 | S | D | 5,012 | $7.93 | 46,734 | D | — | — | |
| 2 | Common | Common stock | 2022-10-27 | A | A | 20,000 | $0.00 | 51,746 | D | — | — |